Atomwise

AtomwiseAtomwise
Atomwise

Atomwise

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

DR 602012Inactive15San Francisco, United States
Rate

About

Atomwise leverages artificial intelligence to accelerate the discovery of novel small molecule therapeutics. Their AtomNet® platform uses deep learning to predict the binding of small molecules to target proteins, significantly reducing the time and cost associated with traditional drug discovery methods.
Frequently asked

What does Atomwise do?

Atomwise leverages artificial intelligence to accelerate the discovery of novel small molecule therapeutics. Their AtomNet® platform uses deep learning to predict the binding of small molecules to target proteins, significantly reducing the time and cost associated with traditional drug discovery methods.

What is Atomwise's revenue?

StartupHub estimates Atomwise's annual revenue at $3.5M (range $1.8M to $8.4M, 67% confidence), based on comparable companies in the sector.

What is Atomwise's valuation?

StartupHub estimates Atomwise's effective valuation at $968.5M (range $590.8M to $1.4B, 10% confidence), based on comparable companies in the sector.

How much funding has Atomwise raised?

Atomwise has raised a total of $236M in funding. The most recent round on record is Grant.

Where is Atomwise headquartered?

Atomwise is headquartered in San Francisco, United States.

When was Atomwise founded?

Atomwise was founded in 2012.

What industry does Atomwise operate in?

Atomwise operates in Drug Discovery, Life Sciences, Healthcare, Drug Discovery AI, Biotech, MedTech.

How many employees does Atomwise have?

Atomwise has approximately 15 people on record.

What is Atomwise's current status?

Atomwise's current operating status is: Inactive.

HEADCOUNT
15
DOMAIN RATING
60
Comments

No comments yet. Be the first to share your take.